Published June 23, 2026
The Journal of the American Medical Association is at it again, with yet another downright deceptive pro-choice study, this time alleging that state pro-life laws lead to worse care for pregnant women who suffer miscarriages.
Planned Parenthood announced: “JAMA’s study finds that patients in states where abortion is banned at or before six weeks of pregnancy were less likely to be given the best standard of care medication to manage their miscarriages and more likely to face delays in treatment.”
In a brazen attempt to increase the availability of abortion, the study’s authors contend that women who experience an early miscarriage should be given the abortion pill regimen—mifepristone followed by misoprostol—to speed up the process. The authors then attack pro-life states because doctors in these states have not rapidly adopted this off-label use of a drug, mifepristone, with a Food and Drug Administration-approved use that is ordinarily illegal in these states.
Click here to continue reading.
Jamie Bryan Hall is the Director of Data Analysis and a Fellow in the Life and Family Initiative at the Ethics and Public Policy Center.
